Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Malignant Solid Tumor × Antibodies, Bispecific × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 1 Malignant Solid Tumor 1 Lymphoma 1 Hematologic Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Tumor 1

Interventions

pembrolizumab 3 Ramucirumab 2 etirinotecan pegol 1 cemiplimab 1 Paclitaxel 1 Nivolumab 1 Injections 1 Fluorouracil 1 Docetaxel 1 Decitabine 1 Cisplatin 1 Carboplatin 1 Antibodies, Bispecific 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04076137 2019-09-03

Targeted T-cell Therapy in Solid Tumors

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡